Transforming Potential of Emerging Human Retroviruses

新兴人类逆转录病毒的转化潜力

基本信息

  • 批准号:
    7455693
  • 负责人:
  • 金额:
    $ 22.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-25 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Human T cell leukemia virus type 1 (HTLV-1) was the first discovered pathogenic human retrovirus. HTLV-1, the etiologic agent of adult T cell leukemia (ATL), encodes a viral oncoprotein, Tax that is necessary and sufficient for viral transformation. HTLV-1 is the prototypic member of a human retrovirus family that also includes HTLV-2, which has not been definitively linked to any human disease. HTLV-1 and -2 are closely related to the simian T cell leukemia viruses, STLV-1 and -2, respectively. In 2005, the human homologue (HTLV-3) of a third simian retrovirus group, STLV-3, was independently isolated twice from Central African primate hunters, and a third independent isolation of HTLV-3 from humans was recently reported. The genome of the HTLV-3 (2026ND) isolate, in particular the Tax gene, is more closely related to HTLV-1 than to HTLV-2, especially in domains that are thought to be important for transformation. The broad distribution of STLV-3 in African primates and independent isolation of HTLV-3 multiple times from humans, suggest that HTLV-3 is prevalent in Africa. An additional human retrovirus, HTLV-4, was also isolated from an African primate hunter in 2005 and is distinct from all known HTLVs and STLVs. In contrast to HTLV-3, the HTLV-4 genome, in particular the Tax gene, is more closely related to HTLV-2 than to HTLV-1. This application is based on the hypothesis that the HTLV-3 Tax protein possesses oncogenic properties while the HTLV- 4 Tax protein does not. This hypothesis will be investigated in two specific aims that focus on determining the transforming potential, transcriptional activity, and protein interacting partners of the HTLV-3 and HTLV-4 Tax proteins. Since HTLV-3 and HTLV-4 appear to be emerging as new human retroviruses, it is critical that we determine the potential of these viruses to cause disease in humans. PUBLIC HEALTH RELEVANCE: Viruses are important causes of cancer in animals and in humans. One particular virus called HTLV-1 is known to cause a type of leukemia in humans. Two new viruses were recently found in humans and these new viruses are very closely related to HTLV-1. Therefore, we think that at least one of the new viruses may cause cancer in humans. HTLV-1 makes a protein called Tax that is necessary for the virus to cause cancer. We plan to compare the Tax protein made by HTLV-1, with the Tax protein made by each of the two new viruses so that we can determine whether the new viruses are likely to cause human cancer.
描述(由申请人提供):人类T细胞白血病病毒1型(HTLV-1)是首次发现的致病性人类逆转录病毒。HTLV-1是成人T细胞白血病(ATL)的病原体,编码一种病毒癌蛋白Tax,它是病毒转化所必需和充分的。HTLV-1是人类逆转录病毒家族的原型成员,该家族还包括HTLV-2,其尚未明确与任何人类疾病相关。HTLV-1和-2分别与猴T细胞白血病病毒STLV-1和-2密切相关。2005年,第三类猿逆转录病毒组STLV-3的人类同源物(HTLV-3)从中非灵长类狩猎者中独立分离了两次,最近报道了第三次从人类中独立分离HTLV-3。HTLV-3(2026 ND)分离株的基因组,特别是Tax基因,与HTLV-1的关系比与HTLV-2的关系更密切,特别是在被认为对转化重要的结构域中。STLV-3在非洲灵长类动物中的广泛分布和HTLV-3多次从人类中独立分离,表明HTLV-3在非洲流行。另一种人类逆转录病毒HTLV-4也于2005年从非洲灵长类动物猎人中分离出来,与所有已知的HTLV和STLV不同。与HTLV-3相反,HTLV-4基因组,特别是Tax基因,与HTLV-2比与HTLV-1更密切相关。本申请基于HTLV-3 Tax蛋白具有致癌特性而HTLV- 4 Tax蛋白不具有的假设。这一假设将在两个特定的目标,重点是确定转化潜力,转录活性,蛋白质相互作用的合作伙伴的HTLV-3和HTLV-4税务蛋白进行调查。由于HTLV-3和HTLV-4似乎是作为新的人类逆转录病毒出现的,因此我们确定这些病毒在人类中引起疾病的潜力至关重要。公共卫生相关性:病毒是动物和人类癌症的重要原因。一种叫做HTLV-1的特殊病毒已知会导致人类的一种白血病。最近在人类中发现了两种新病毒,这些新病毒与HTLV-1非常密切相关。因此,我们认为至少有一种新病毒可能导致人类癌症。HTLV-1产生一种名为Tax的蛋白质,这种蛋白质是病毒致癌所必需的。我们计划将HTLV-1产生的Tax蛋白与两种新病毒产生的Tax蛋白进行比较,以便确定新病毒是否可能导致人类癌症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUSAN J MARRIOTT其他文献

SUSAN J MARRIOTT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUSAN J MARRIOTT', 18)}}的其他基金

Development of a Novel Mouse Model to Evaluate HTLV Tax Transformation
开发新的小鼠模型来评估 HTLV 税收转型
  • 批准号:
    8637946
  • 财政年份:
    2013
  • 资助金额:
    $ 22.33万
  • 项目类别:
Development of a Novel Mouse Model to Evaluate HTLV Tax Transformation
开发新的小鼠模型来评估 HTLV 税收转型
  • 批准号:
    8488975
  • 财政年份:
    2013
  • 资助金额:
    $ 22.33万
  • 项目类别:
Transforming Potential of Emerging Human Retroviruses
新兴人类逆转录病毒的转化潜力
  • 批准号:
    7690756
  • 财政年份:
    2008
  • 资助金额:
    $ 22.33万
  • 项目类别:
Mechanisms of Cellular Transformation by HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    7350884
  • 财政年份:
    1999
  • 资助金额:
    $ 22.33万
  • 项目类别:
Mechanisms of Cellular Transformation by HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    6687008
  • 财政年份:
    1999
  • 资助金额:
    $ 22.33万
  • 项目类别:
Mechanisms of Cellular Transformation by HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    7213356
  • 财政年份:
    1999
  • 资助金额:
    $ 22.33万
  • 项目类别:
Mechanisms of Cellular Transformation by HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    6876139
  • 财政年份:
    1999
  • 资助金额:
    $ 22.33万
  • 项目类别:
MECHANISM OF CELLULAR TRANSFORMATION BY HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    6150322
  • 财政年份:
    1999
  • 资助金额:
    $ 22.33万
  • 项目类别:
MECHANISM OF CELLULAR TRANSFORMATION BY HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    2849538
  • 财政年份:
    1999
  • 资助金额:
    $ 22.33万
  • 项目类别:
MECHANISM OF CELLULAR TRANSFORMATION BY HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    6497467
  • 财政年份:
    1999
  • 资助金额:
    $ 22.33万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.33万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 22.33万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 22.33万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 22.33万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 22.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 22.33万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 22.33万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了